Who was studied?
Planned enrollment: 29 patients aged 75 years or older with advanced solid tumors.
What does the publication report?
A prospective, single-arm phase II study is planned. The enrollment target is not a completed patient count.
Safety findings
Prospective safety evaluation is planned; no observed event rates are reported in this protocol.
How should we interpret it?
This is a study protocol, not a report of treatment results. Planned enrollment and endpoints are not observed outcomes.
Read the original source
This independently written summary was checked against the publicly available abstract. Selected figures, where included, are checked against the full publication. This is not a full-paper translation or a clinical recommendation.
Efficacy and Safety of PRaG Therapy in Elderly Patients with Advanced Malignant Tumors: A Prospective, Multicenter Clinical Study Protocol (PRaG 9.0 Study) · DOI: 10.1177/15330338251400412 · PMID: 41308040
Educational reporting, not individualized medical advice. Discuss treatment decisions with your clinical team.